RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
Akron, OH · Cincinnati, OH · +18 more sites
3 recruiting migraine studies with a site in Akron, OH.
Sponsor: H. Lundbeck A/S
Akron, OH · Cincinnati, OH · +18 more sites
Sponsor: H. Lundbeck A/S
Akron, OH · Cincinnati, OH · +13 more sites
Sponsor: Pfizer
Akron, OH · Cincinnati, OH · +166 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.